Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine

Regulator Reviewing Reports of ‘Rare’ and Serious Condition Linked to Moderna Vaccine
Vials of Moderna's COVID-19 vaccine are seen in Bridgeport, Conn., in a file photograph. Joseph Prezioso/AFP via Getty Images
Jack Phillips
Updated:

Europe’s drug regulator on Thursday confirmed it is investigating reports of a blood condition in recipients of Moderna’s mRNA COVID-19 vaccine.

According to a bulletin posted by the European Medicines Agency (EMA), it is reviewing six cases of capillary leak syndrome, considered a “very rare disorder,” after they were reported in the EMA’s EudraVigilance database.
Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics